Skip to main content
James Hermiller Jr., MD, Cardiology, Indianapolis, IN, Hendricks Regional Health

JamesBHermillerJr.MD

Cardiology Indianapolis, IN

Adult Congenital Heart Disease, Cardiac Electrophysiology, Interventional Cardiology

Physician

Dr. Hermiller is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Hermiller's full profile

Already have an account?

Education & Training

  • Duke University Hospital
    Duke University HospitalFellowship, Cardiovascular Disease, 1989 - 1992
  • National Capital Consortium
    National Capital ConsortiumResidency, Internal Medicine, 1983 - 1986
  • Ohio State University College of Medicine
    Ohio State University College of MedicineClass of 1983

Certifications & Licensure

  • IN State Medical License
    IN State Medical License 1992 - 2025
  • NC State Medical License
    NC State Medical License 1991 - 1998
  • MD State Medical License
    MD State Medical License 1988 - 1990
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

  • Fellow (FACC) American College of Cardiology

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Delivering Evidence 
    CRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/26/2019
  • AMULET: Device Characteristics, Procedural Technique, Clinical Outcomes, and Ongoing Studies 
    CRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/26/2019
  • The Growing Concern of Coronary Access After TAVR: Procedural Problem-Solving and Impact on TAVR Device Choices 
    CRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/26/2019
  • Join now to see all

Press Mentions

  • Encouraging 3-Year Data for TAVR in Low-Risk Patients: EVOLUT
    Encouraging 3-Year Data for TAVR in Low-Risk Patients: EVOLUTMarch 8th, 2023
  • PCI-Related MIs Not Linked to Mortality at 1 Year: Onyx ONE
    PCI-Related MIs Not Linked to Mortality at 1 Year: Onyx ONEFebruary 25th, 2020
  • Treating Mitral Regurgitation in High Risk Patients
    Treating Mitral Regurgitation in High Risk PatientsJanuary 14th, 2019
  • Join now to see all

Professional Memberships

Hospital Affiliations